Noncompaction cardiomyopathy screening: Difference between revisions
(New page: {{Noncompaction cardiomyopathy}} {{CMG}} ==Overview== ==References== {{Reflist|2}} Category:Cardiology Category:Overview complete) |
No edit summary |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Noncompaction cardiomyopathy is an inheritable disease, and if a family member is affected, consideration should be given to screening other family members. | |||
At least one genetic abnormality has been identified in the gene that encodes for [[alpha-dystrobrevin]]. This is a [[dystrophin-associated protein]] which has been mapped to [[chromosome 18q12]]. The role of this protein is to preserve the structural integrity of the muscle membrane. | |||
==References== | ==References== |
Revision as of 14:10, 3 August 2011
Noncompaction Cardiomyopathy Microchapters |
Pathophysiology |
---|
Differentiating Noncompaction Cardiomyopathy from other Diseases |
Diagnosis |
Treatment |
Noncompaction cardiomyopathy screening On the Web |
Risk calculators and risk factors for Noncompaction cardiomyopathy screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Noncompaction cardiomyopathy is an inheritable disease, and if a family member is affected, consideration should be given to screening other family members.
At least one genetic abnormality has been identified in the gene that encodes for alpha-dystrobrevin. This is a dystrophin-associated protein which has been mapped to chromosome 18q12. The role of this protein is to preserve the structural integrity of the muscle membrane.